Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial

Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer:... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Cancer Unpaywall

Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial

Loading next page...
 
/lp/unpaywall/eribulin-mesilate-versus-vinorelbine-in-women-with-locally-recurrent-4mEOIbbHfK

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Unpaywall
ISSN
0959-8049
DOI
10.1016/j.ejca.2019.02.002
Publisher site
See Article on Publisher Site

Abstract

Journal

European Journal of CancerUnpaywall

Published: May 1, 2019

There are no references for this article.